Clinical trial
Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery
NCT00813397 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- July 31, 2009
- Enrollment
- 210 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
adhesion prevention